In a video interview at Life Sciences Patents Network Europe 2016, a conference hosted in London last week by LSIPR, Marjan Noor of Allen & Overy discusses developments around second medical use patents.
Noor says in the interview: “The biggest challenge is how you ensure that generic companies are allowed to sell for uses that are permitted off patent uses.”
